Current Search:  blaber (x) » Blaber, Michael (x)

Search results

  • CSV Spreadsheet
(1 - 50 of 109)

Pages

Small animal restraining harness or jacket
9783587
Accelerated healing in NONcNZO10/LtJ type 2 diabetic mice by FGF 1
Mutant polypeptides of fibroblast growth factor 1
Mutant polypeptides of fibroblast growth factor 1
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutant polypeptides of fibroblast growth factor 1
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Engineered human acidic fibroblast growth factors and associated methods
SYMMETRIC PROTEIN ARCHITECTURE IN PROTEIN DESIGN: TOP-DOWN SYMMETRIC DECONSTRUCTION
Prebiotic Protein Design supports a Halophile Origin of Foldable Proteins
Prebiotic protein design supports a halophile origin of foldable proteins.
Experimental support for the evolution of symmetric protein architecture from a simple peptide motif.
Experimental Support for the Evolution of Symmetric Protein Architecture from a Simple          Peptide Motif
Method of treating multiple sclerosis with anti-K6 antibody
Functional Intersection of the Kallikrein-Related Peptidases (KLKs) and Thrombostasis          Axis
Kallikrein-related Peptidase 6
Pharmacokinetic Properties of 2(nd)-Generation Fibroblast Growth Factor-1 Mutants for          Therapeutic Application
X-ray Structure and Biophysical Properties of Rabbit Fibroblast Growth Factor 1
X-ray structure and biophysical properties of rabbit fibroblast growth factor 1.
Autolytic Regulation of Human Kallikrein-Related Peptidase 6
Activation Profiles of Human Kallikrein-Related Peptidases by Matrix          Metalloproteinases
Mutation Choice to Eliminate Buried Free Cysteines in Protein Therapeutics
Simplified Protein Design Biased for Pre-Biotic Amino Acids Yields a Foldable, Halophilic Protein
Simplified protein design biased for prebiotic amino acids yields a foldable, halophilic protein.
Emergence of Symmetric Protein Architecture from a Simple Peptide Motif
Experimental support for the foldability-function tradeoff hypothesis
Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.
Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.
autolytic regulation of human kallikrein-related peptidase 6.
Completed KLK Activome Profile
Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals a Trypsin-like Kallikrein is Expressed in the Central Nervous System
Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Engineering an Improved Crystal Contact Across a Solvent-Mediated Interface of Human          Fibroblast Growth Factor 1
Engineering an improved crystal contact across a solvent-mediated interface of human fibroblast growth factor 1.
Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma          Microenvironment
Kallikrein 6 Signals through PAR1 and PAR2 to Promote Neuron Injury and Exacerbate Glutamate Neurotoxicity
Kallikrein 6 is a Novel Molecular Trigger of Reactive Astrogliosis
Protease-Activated Receptor Dependent and Independent Signaling by Kallikreins 1 and 6          in CNS Neuron and Astroglial Cell Lines
S(1)' and S(2)' Subsite Specificities of Human Plasma Kallikrein and Tissue Kallikrein          1 for the Hydrolysis of Peptides Derived from the Bradykinin Domain of Human          Kininogen
Activation Profiles of Human Kallikrein-Related Peptidases by Proteases of the          Thrombostasis Axis
Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "2nd Generation" Therapeutic Application
Molecular Modeling of Substrate Binding in Wild-type and Mutant Corynebacteria 2,5-diketo-D-gluconate Reductases
Investigating the Dynamics and Polyanion Binding Sites of Fibroblast Growth Factor-1 Using Hydrogen-Deuterium Exchange Mass Spectrometry
Single Aromatic Core Mutation Converts a Designed "Primitive" Protein from Halophile to Mesophile Folding

Pages